Hemptown Organics is unique in the legalized cannabis sector as the company remained under the public market radar until its operations were actually operational.
Speaking of which, the company brought in 110,000 pounds of feminized hemp biomass in 2018 and purchased one million rare CBG seeds to plant in 2019.
Hemptown also has the confidence of financial institutions, having just over-subscribed a convertible debenture offering for CAD$24 million and its not hard to understand why.
In the first half of this fiscal cycle, Hemptown is reporting the same caliber of revenues as billion-dollar ‘juggernaut’ Cronos Group (CRON.T), but Hemptown has a realistic market cap with room to fly.
Equity.Guru’s own Chris Parry, spoke with Hemptown co-founder, director and president, Michael Townsend, to lift up the hood on the company, its revenue run and its highly anticipated IPO expected in Q4 2019.
Full disclosure: Hemptown Organics is an Equity.Guru marketing client.Disclaimer: ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.
Latest posts by Chris Parry (see all)
- Draganfly (DFLY.C) drone innovator nabs former US govt official as director - November 7, 2019
- Equity.Guru podcast: 1933 Industries (TGIF.C) focuses on fundamentals in legal cannabis market, who woulda thunk it? - November 6, 2019
- MedMen (MMEN.C) yearly loss was $1m more than Supreme Cannabis’ (FIRE.T) entire market cap - October 28, 2019